Información de Teva Pharmaceutical Industries Ltd, dividendo de Teva Pharmaceutical Industries Ltd, actividades de los accionistas y más

Más Datos de Teva Pharmaceutical Industries Ltd Compañía

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Información de la empresa

Código de la empresaTEVA

Nombre de la empresaTeva Pharmaceutical Industries Ltd

Fecha de salida a bolsaJan 01, 1951

Fundada en1944

Director ejecutivoMr. Richard D. Francis

Número de empleados33892

Tipo de seguridadOrdinary Share

Fin del año fiscalJan 01

Dirección124 Dvora Hanevi'a St.

CiudadTEL AVIV-YAFO

Bolsa de valoresTel Aviv Stock Exchange

PaísIsrael

Código postal6944020

Teléfono97239148213

Sitio Webhttps://www.tevapharm.com/

Código de la empresaTEVA

Fecha de salida a bolsaJan 01, 1951

Fundada en1944

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Prof. Varda Shalev

Independent Director

12.87K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Prof. Varda Shalev

Independent Director

12.87K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

11.91K

--

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Desglose de ingresos

Divisa: USDHora de actualización: dom., 6 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

8.03B

48.56%

Europe

5.10B

30.85%

International Markets

2.46B

14.89%

Other

944.00M

5.71%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Generic products

9.46B

57.19%

AUSTEDO

1.69B

10.20%

Anda

1.54B

9.28%

Other

1.38B

8.32%

AJOVY

507.00M

3.06%

Other

1.98B

11.94%

Accionista

Hora de actualización: hace 14 horas

Estadísticas de accionistas

Tipo

Estadísticas de accionistas

Accionista

Proporción

Fidelity Management & Research Company LLC

6.63%

Clal Insurance Enterprises Holdings Ltd.

3.40%

Ion Asset Management Israel Ltd

3.20%

BlackRock Institutional Trust Company, N.A.

2.89%

Menora Mivtachim Insurance Ltd.

2.47%

Other

81.42%

Estadísticas de accionistas

Accionista

Proporción

Fidelity Management & Research Company LLC

6.63%

Clal Insurance Enterprises Holdings Ltd.

3.40%

Ion Asset Management Israel Ltd

3.20%

BlackRock Institutional Trust Company, N.A.

2.89%

Menora Mivtachim Insurance Ltd.

2.47%

Other

81.42%

Tipo

Accionista

Proporción

Investment Advisor

25.91%

Investment Advisor/Hedge Fund

13.09%

Hedge Fund

12.84%

Insurance Company

4.75%

Research Firm

2.36%

Pension Fund

1.85%

Bank and Trust

0.94%

Family Office

0.81%

Sovereign Wealth Fund

0.20%

Other

37.25%

Participación institucional

Hora de actualización: lun., 20 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q1

1071

683.47M

59.65%

-18.19M

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

2023Q1

927

576.84M

51.93%

-50.26M

2022Q4

946

573.39M

51.61%

-69.40M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Fidelity Management & Research Company LLC

76.01M

6.63%

+14.91M

+24.41%

Dec 31, 2024

Clal Insurance Enterprises Holdings Ltd.

38.96M

3.4%

+4.42M

+12.79%

Dec 31, 2024

Ion Asset Management Israel Ltd

36.65M

3.2%

+409.78K

+1.13%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

33.10M

2.89%

+786.74K

+2.43%

Dec 31, 2024

Menora Mivtachim Insurance Ltd.

28.38M

2.48%

-456.80K

-1.58%

Dec 31, 2024

Lingotto Investment Management LLP

27.19M

2.37%

+688.86K

+2.60%

Dec 31, 2024

Migdal Insurance and Financial Holdings Ltd

26.04M

2.27%

+569.41K

+2.24%

Dec 31, 2024

Phoenix Investment and Finances Ltd

21.21M

1.85%

-1.35M

-5.98%

Dec 31, 2024

State Street Global Advisors (US)

19.41M

1.69%

-86.64K

-0.44%

Dec 31, 2024

ETFs relacionados

Hora de actualización: dom., 6 de abr

Nombre

Proporción

VanEck Israel ETF

7.39%

iShares MSCI Israel ETF

7.06%

VanEck Pharmaceutical ETF

4.4%

Tema Neuroscience and Mental Health ETF

4.26%

Amplify Weight Loss Drug & Treatment ETF

3.49%

AdvisorShares Dorsey Wright ADR ETF

2.35%

ARK Israel Innovative Technology ETF

1.46%

Amplify International Enhanced Dividend Income ETF

1.33%

FIS Christian Stock Fund ETF

0.91%

Affinity World Leaders Equity ETF

0.9%

VanEck Israel ETF

Proporción7.39%

iShares MSCI Israel ETF

Proporción7.06%

VanEck Pharmaceutical ETF

Proporción4.4%

Tema Neuroscience and Mental Health ETF

Proporción4.26%

Amplify Weight Loss Drug & Treatment ETF

Proporción3.49%

AdvisorShares Dorsey Wright ADR ETF

Proporción2.35%

ARK Israel Innovative Technology ETF

Proporción1.46%

Amplify International Enhanced Dividend Income ETF

Proporción1.33%

FIS Christian Stock Fund ETF

Proporción0.91%

Affinity World Leaders Equity ETF

Proporción0.9%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

Teva Pharmaceutical Industries Ltd

15.575USD

Teva Pharmaceutical Industries Ltd

15.575

Descripción general

Compañía